1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Central Nervous System Disease in 1 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M | 1 |
| Liu, A | 1 |
| Ouyang, Y | 1 |
| Huang, Y | 1 |
| Chao, X | 1 |
| Pi, R | 1 |
1 review available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Central Nervous System Disease
| Article | Year |
|---|---|
Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disorders?
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Central Nervous System Diseases; Humans; Pro | 2013 |